Arch Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arch Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2020 to Q3 2022.
  • Arch Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $0.000.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $0 $0 Sep 30, 2022 10-K 2022-12-28
Q4 2021 $10K -$20K -66.7% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $0 -$39K -100% Sep 30, 2021 10-K 2022-12-28
Q2 2021 $10K Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $20K Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $30K Dec 31, 2020 10-Q 2021-02-12
Q3 2020 $39K Sep 30, 2020 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.